| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |